Abstract
The past two decades have witnessed an increase in prevalence of food allergy that has been matched with a tremendous progress in research that has led to better understanding of pathogenic mechanisms and development of novel therapies for food allergy. Establishment of murine models of peanut and cows milk allergy has been extremely useful in investigating food allergy treatments. Diverse strategies for prevention and treatment of established food allergy are being evaluated. Anti-IgE antibody therapy, Chinese herbal medicines, and killed bacteria expressing modified major peanut allergens represent the most promising approaches that will lead to development of therapy for patients for whom no effective treatment is currently available.
Keywords: Food allergy, immunotherapy, food hypersensitivity, therapy for food allergy
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Immunotherapy for Food Allergy
Volume: 5 Issue: 1
Author(s): Anna Nowak-Wegrzyn
Affiliation:
Keywords: Food allergy, immunotherapy, food hypersensitivity, therapy for food allergy
Abstract: The past two decades have witnessed an increase in prevalence of food allergy that has been matched with a tremendous progress in research that has led to better understanding of pathogenic mechanisms and development of novel therapies for food allergy. Establishment of murine models of peanut and cows milk allergy has been extremely useful in investigating food allergy treatments. Diverse strategies for prevention and treatment of established food allergy are being evaluated. Anti-IgE antibody therapy, Chinese herbal medicines, and killed bacteria expressing modified major peanut allergens represent the most promising approaches that will lead to development of therapy for patients for whom no effective treatment is currently available.
Export Options
About this article
Cite this article as:
Nowak-Wegrzyn Anna, Immunotherapy for Food Allergy, Inflammation & Allergy - Drug Targets (Discontinued) 2006; 5 (1) . https://dx.doi.org/10.2174/187152806775269349
DOI https://dx.doi.org/10.2174/187152806775269349 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Protein Oxidative Folding in the Intermembrane Mitochondrial Space: More than Protein Trafficking
Current Protein & Peptide Science Mucosal Healing in Crohn’s Disease: Relevance for Clinical Outcomes
Current Drug Targets Recent Advances on the Enantioselective Synthesis of C-Nucleosides Inhibitors of Inosine Monophosphate Dehydrogenase (IMPDH)
Current Topics in Medicinal Chemistry Astrocytes: From the Physiology to the Disease
Current Alzheimer Research Patent Perspectives for Corticosteroids Based Ophthalmic Therapeutics
Recent Patents on Drug Delivery & Formulation Cytokine Gene Polymorphisms in Cancer and Inflammatory Disorders
Current Immunology Reviews (Discontinued) Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy
Current Pharmaceutical Design Nickel Allergy: Epidemiology, Pathomechanism, Clinical Patterns, Treatment and Prevention Programs
Endocrine, Metabolic & Immune Disorders - Drug Targets Dendritic Cell-Based Therapies in the Bench and the Bedsides
Current Drug Targets - Inflammation & Allergy Dysfunctional Adaptive Immunity During Parasitic Infections
Current Immunology Reviews (Discontinued) Design, Synthesis and Molecular Docking Studies of Some Thiazole Clubbed Heterocyclic Compounds as Possible Anti-infective Agents
Letters in Organic Chemistry The Role of ABCG2 and ABCB6 in Porphyrin Metabolism and Cell Survival
Current Pharmaceutical Biotechnology Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
Reviews on Recent Clinical Trials The Connections Among Autophagy, Inflammasome and Mitochondria
Current Drug Targets Drugs and Foods for Chronic Subclinical Inflammation in Humans
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Advances in Long-Circulating Drug Delivery Strategy
Current Drug Metabolism Human Endotoxemia as a Model of Systemic Inflammation
Current Medicinal Chemistry Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications
Current Drug Targets Concomitant Gene Mutations of MBL and CYBB in Chronic Granulomatous Disease: Implications for Host Defense
Inflammation & Allergy - Drug Targets (Discontinued)